pillbase.ru

Orserdu

Active substance: elacestrant

elacestrant

Centralised EU authorisationActive

Marketing holder: Stemline Therapeutics B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • ORSERDU
    TABLET, FILM COATED · ELACESTRANT 86 mg/1
    72187-0101
    Stemline Therapeutics, Inc.
  • ORSERDU
    TABLET, FILM COATED · ELACESTRANT 345 mg/1
    72187-0102
    Stemline Therapeutics, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208f-00a4-7957-95ec-c336384d7d46,01a1208f-00a8-79d3-a053-8fb593d61c7e;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005898
Registration status
Active
ATC code
L02BA
Sources
  • product · EMA · EMEA/H/C/005898 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005898 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005898 · Verified 2026-10-09